Can you take zinc and Zofran?
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
47 Citations | MEASUREMENTS AND RESULTS Zinc metabolism was studied with an oral dose of zinc chloride Zn 65 and whole-body counting at both zinc dosages. |
122 Citations | The authors present a new model of zinc currents and zinc toxicity that offers expanded opportunities for zinc-selective therapeutic chelation interventions. |
| Zinc histidine complexes are better absorbed than zinc sulfate in humans. | |
01 Dec 2005 19 Citations | Zinc absorption in humans could be improved by zinc complexation with gluconate. |
| Both young and elderly women reduced their efficiency of zinc absorption with zinc supplementation. |
My columns
Related Questions
See what other people are reading
What is the impact of boiling ginger on secondary metabolites like gingerol and shogaol?
5 answers
Boiling ginger has a significant impact on secondary metabolites like gingerol and shogaol. The process of boiling ginger rhizomes alters the composition of these active compounds due to the influence of temperature. Studies have shown that the thermal processing of ginger can lead to changes in the content and transformation of compounds, affecting the overall composition of the plant matrix. Additionally, the metabolism of ginger compounds like gingerols and shogaols in humans has been studied, revealing that these components undergo ketone reduction and cysteine conjugation pathways, producing various metabolites with potential health benefits. Therefore, boiling ginger can impact the levels and types of secondary metabolites present, potentially influencing the therapeutic properties of the plant.Why is villi height a good marker of intestinal health?5 answers
Villi height is a valuable marker of intestinal health due to its association with crucial functions in the small intestine. Studies have shown that villi height correlates with the absorption capacity of nutrients, impacting overall body weight. Additionally, villi play a significant role in the amplification of the internal surface area of the intestine, enhancing nutrient absorption. Furthermore, alterations in villus morphology are linked to metabolic perturbations, affecting processes like gut microbial metabolism and energy metabolism, which are essential for overall health. The height of villi reflects the state of villus health, with shorter villi being associated with reduced microbial metabolism and muscle metabolism, highlighting the importance of villi height as a marker for intestinal health.Can medium chain triglycerides improve digestion?4 answers
Medium-chain triglycerides (MCTs) have shown potential in improving digestion based on research findings. Studies have highlighted that MCTs, when incorporated into structured lipids like EPA-rich medium- and long-chain triacylglycerol (MLCT), can enhance the hydrolysis process during digestion, leading to higher free fatty acid release levels compared to other oils. Additionally, MCTs, commonly used in infant formulas, have been compared to human milk containing medium- and long-chain triacylglycerols (MLCTs), with MLCTs showing a different impact on lipolysis and free fatty acid profiles, potentially affecting infant health. Furthermore, the digestion behaviors of different triglycerides, including MCTs, in dynamic and static simulation models have demonstrated varying digestibility rates, with MCTs exhibiting favorable digestibility characteristics. Overall, incorporating MCTs, especially in structured lipids, may contribute to improved digestion processes.What factors inflence the albumin cocnetration in the dermal interstitial ffluid?5 answers
The concentration of albumin in the dermal interstitial fluid is influenced by several factors. Negatively charged glycosaminoglycans in the extracellular matrix play a significant role in the exclusion of albumin from the interstitial space. Hydration levels also impact the exclusion of albumin, with reduced hydration leading to a diminished effect of negative charges on interstitial exclusion of charged macromolecules. Additionally, the composition of the interstitial matrix, particularly collagen and hyaluronan, affects the exclusion of albumin, with collagen and hyaluronan being responsible for a significant portion of the exclusion volume. These factors collectively contribute to the regulation of albumin concentration in the dermal interstitial fluid.What are the current clinical trials evaluating the safety and efficacy of rezafungin in the treatment of candidiasis?10 answers
Rezafungin is a next-generation echinocandin undergoing evaluation in clinical trials for its safety and efficacy in treating candidiasis, including candidemia and invasive candidiasis (IC). The ReSTORE trial (NCT03667690) is a pivotal Phase 3, global, double-blind, randomized, controlled non-inferiority trial comparing rezafungin administered once weekly to caspofungin given once daily in patients with candidemia and/or IC. This trial demonstrated rezafungin's non-inferiority to caspofungin in terms of global cure at day 14 and all-cause mortality at day 30, highlighting its potential as an effective treatment option for candidiasis.
A sub-analysis of the ReSTORE trial focused on immunocompromised patients, revealing that while immune-compromised status reduced efficacy rates overall, it did not significantly alter the efficacy rate differences between rezafungin and caspofungin, suggesting rezafungin's consistent performance across different patient subgroups. Additionally, the STRIVE trial (Phase 2; NCT02734862) and ReSTORE trial data were analyzed together, providing further evidence of rezafungin's efficacy and safety, with comparable 30-day all-cause mortality rates and safety profiles to caspofungin.
Rezafungin's drug-drug interaction profile has also been extensively studied, showing a low potential for interactions with commonly prescribed medications, which is crucial for the treatment of life-threatening infections in patients who may be on multiple drugs. Furthermore, in vitro studies have supported rezafungin's activity against a wide range of Candida species and other fungi, reinforcing its potential utility in treating candidiasis.
Overall, the clinical trials and studies conducted so far indicate that rezafungin is a promising candidate for the treatment of candidiasis, offering a favorable safety profile, efficacy across multiple Candida species, and a convenient dosing regimen that could improve patient compliance.What are the current clinical trials assessing the safety and efficacy of rezafungin in the treatment of candidiasis?9 answers
Rezafungin is a next-generation echinocandin undergoing clinical trials to assess its safety and efficacy in treating candidiasis, with significant developments reported from the ReSTORE and STRIVE trials. The ReSTORE trial, a Phase 3 non-inferiority study, compared once-weekly rezafungin to daily caspofungin in patients with candidemia and/or invasive candidiasis (IC), demonstrating rezafungin's non-inferiority in terms of efficacy and safety. This trial highlighted rezafungin's effectiveness across multiple Candida species, without a clear correlation between increased minimum inhibitory concentration (MIC) values and clinical outcomes, suggesting its broad applicability in treating candidiasis. The STRIVE trial, a Phase 2 study, further supported rezafungin's efficacy and safety profile, contributing to a comprehensive understanding of its therapeutic potential.
Sub-analyses of the ReSTORE trial provided insights into specific patient populations, including those with compromised immune systems, where rezafungin's efficacy was slightly reduced but remained comparable to caspofungin. Additionally, outcomes stratified by renal function indicated that rezafungin's efficacy was consistent across different levels of renal impairment, with a notable reduction in all-cause mortality (ACM) and higher mycological eradication rates in the moderate to severe impairment group compared to caspofungin.
Drug-drug interaction studies have shown rezafungin to have a low potential for interactions with commonly prescribed medications, including immunosuppressants and cancer therapies, which is crucial for its use in vulnerable patient populations. Furthermore, rezafungin's pharmacokinetic profile supports its once-weekly dosing regimen, potentially improving patient compliance and treatment outcomes.
Overall, the clinical trials assessing rezafungin, including ReSTORE and STRIVE, have demonstrated its safety and efficacy in treating candidiasis, with additional benefits such as a favorable drug-drug interaction profile and consistent efficacy across various patient subgroups.Why contact angle of thin films decreases with increasing doping concentration ZnO?5 answers
The contact angle of thin films decreases with increasing doping concentration in ZnO due to various factors observed in different studies. For instance, in Zn-doped SnO2 films, the contact angle decreased with increasing Zn doping, indicating a hydrophilic nature of the films. Similarly, in Cu-doped ZnO films, an increase in Cu doping led to changes in surface energy and wettability behaviors, as evidenced by water contact angle measurements. Moreover, in Mg-doped ZnO films, the contact angle decreased with the increase of Mg concentration, showcasing a transition from hydrophobic to hydrophilic behavior. These findings collectively suggest that doping concentration influences the surface properties of thin films, affecting their wetting behavior and contact angle measurements.What properties of photocatalyst do i need for RWGS reaction?4 answers
For the RWGS (reverse water-gas shift) reaction, essential properties of a photocatalyst include high activity, stability, and selectivity towards CO production. Catalysts with bimetallic compositions like Ni-Cu or Ni-Mo show enhanced activity and stability. The catalyst's structure, composition, and dispersion of active species significantly impact its performance. For instance, the distribution of Ni throughout the catalyst particle and the presence of active species like Nio and NiAl2O4 are crucial for catalytic activity. Additionally, the presence of oxygen vacancies in the catalyst, such as Mg(Al,Ni)O vacancies, plays a vital role in the reduction of CO2 to CO, highlighting the importance of specific active sites for RWGS reaction. Therefore, a well-designed photocatalyst with optimized composition, structure, and active sites is essential for efficient CO production in the RWGS reaction.What are the examples and draw back of conventional drug delivery in form of unencapsulated formula?4 answers
Conventional unencapsulated drug delivery systems face various drawbacks, including poor bioavailability, rapid blood level spikes, hepatic first-pass metabolism, and low therapeutic efficacy due to factors like metabolic inactivation and low permeability. Examples of such systems include ophthalmic solutions, emulsions, suspensions, ointments, and polymeric gels for ocular drug delivery. Similarly, oral conventional dosage forms suffer from limitations like low bioavailability and the need for high or frequent dosing, leading to inconvenience and uneconomical treatment approaches. These challenges highlight the urgent need for advanced drug delivery systems, such as nanocarrier-based systems and transdermal drug delivery, to enhance drug efficacy, improve patient compliance, and overcome the limitations associated with conventional unencapsulated formulations.After absorption how much time is required for doxylamine succinate and Pyridoxine hydrochloride to show pharmacological effect?4 answers
After absorption, doxylamine succinate and pyridoxine hydrochloride, as part of a delayed-release combination, exhibit delayed efficacy due to their pharmacokinetic profile. The delayed-release formulation of doxylamine succinate and pyridoxine hydrochloride, known as Diclectin, has a time-to-peak (Tmax) that is 3-6 times longer compared to oral solutions of the individual components, indicating a delayed onset of action. This delayed efficacy is further supported by the fact that the delayed-release combination of doxylamine succinate and pyridoxine hydrochloride shows improved symptom control for nausea and vomiting of pregnancy (NVP) compared to placebo on Days 3, 4, and 5, with sustained efficacy throughout the trial. Therefore, after absorption, it may take several days for doxylamine succinate and pyridoxine hydrochloride to demonstrate their full pharmacological effect due to their delayed-release characteristics.How does Paracetamol and Codeine work together?5 answers
Paracetamol and Codeine, when combined, exhibit synergistic effects in pain management without significant impact on liver enzymes, urea levels, or kidney function in experimental studies on rats and horses. This combination enhances analgesic potential for moderate-to-severe pain by leveraging their distinct mechanisms of action. The analgesic efficacy of Paracetamol and Codeine is well-tolerated and safe, with minimal adverse effects observed in animal models. The combination's effectiveness in pain relief is further supported by its ability to increase thermal thresholds significantly, indicating improved pain control. Overall, the synergistic action of Paracetamol and Codeine offers a promising approach for pain management, highlighting their compatibility and potential benefits when used together.